Allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the treatment of adult T-cell leukemia/lymphoma (ATL): A feasibility study with 11 patients.

被引：0
|
作者：
Yuji, K
Hamaki, T
Kami, M
Kusumi, E
Miyakoshi, S
Ueyama, J
Morinaga, S
Kanda, Y
Tanosaki, R
Mineishi, S
Takaue, Y
Taniguchi, S
Shibuya, T
Chiba, S
Hirai, H
Muroi, K
Ozawa, K
Naohara, T
Kasai, M
Mutou, Y
机构：
[1] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan
[2] Natl Canc Ctr Hosp, Dept Med Oncol, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan
[3] Hamanoumachi Hosp, Div Hematol, Fukuoka, Japan
[4] Tokyo Univ Hosp, Dept Hematol & Oncol, Tokyo 113, Japan
[5] Jichi Med Sch, Div Cell Transplantat & Transfus, Minami Kawachi, Tochigi 32904, Japan
[6] Sapporo Hokuyu Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5333
引用
收藏
页码：388B / 388B
页数：1
相关论文
共 50 条
  • [1] Retrospective analysis of standard allogeneic hematopoietic stem cell transplantation (allo-HSCT) for adult T-cell leukemia (ATL).
    Fukushima, T
    Miyazaki, Y
    Kawano, F
    Moriuchi, Y
    Masuda, M
    Tanosaki, R
    Utsunomiya, A
    Uike, N
    Yoshida, S
    Kuriyama, K
    Tomonaga, M
    BLOOD, 2002, 100 (11) : 456B - 457B
  • [2] Recent Significance of Allogeneic Hematopoietic Stem Cell Transplantation for Adult T Cell Leukemia/Lymphoma (ATL)
    Tokunaga, Masahito
    Nakano, Nobuaki
    Kubota, Ayumu
    Tokunaga, Mayumi
    Itoyama, Takahiro
    Makino, Torahiko
    Takeuchi, Shogo
    Takatsuka, Yoshifusa
    Utsunomiya, Atae
    BLOOD, 2014, 124 (21)
  • [3] Prognosis of Acute Leukemia Patients with Active Disease Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)
    Sahin, U.
    Merter, M.
    Atesagaoglu, B.
    Erdai, H.
    Bozdag, S. Civriz
    Toprak, S. K.
    Yuksel, M. Kurt
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Demirer, T.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S483 - S483
  • [4] Analysis of febrile neutropenia in allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Zerkout, Sara
    Benakli, Malek
    Mehdid, Farih
    Baazizi, Mounira
    Rahmoune, Nadia
    Ouali, Dina Ait
    Bouarab, Hanane
    Belhadj, Rachida
    Tarhi, Kahina
    Benchouk, Chahrazed
    Harieche, Farida
    Hamladji, Rose-Marie
    Nacer, Redhouane Ahmed
    BONE MARROW TRANSPLANTATION, 2019, 54 : 447 - 448
  • [5] Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients
    Gurman, Gunhan
    Atilla, Erden
    Atilla, Pinar Ataca
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Akan, Hamdi
    Ilhan, Osman
    Beksac, Meral
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S275 - S276
  • [6] Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT
    Kato, Koji
    Miyamoto, Toshihiro
    Yonemoto, Koji
    Uchida, Naoyuki
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Takahashi, Satoshi
    Ohashi, Kazuteru
    Eto, Tetsuya
    Nagamura-Inoue, Tokiko
    Sakamaki, Hisashi
    Morishima, Yasuo
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Akashi, Koichi
    BLOOD, 2014, 124 (21)
  • [7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) FOR CHRONIC MYELOID LEUKEMIA (CML): THE TUNISIAN EXPERIENCE
    Torjemane, L.
    Abdejelil, N.
    Lakhal, A.
    Barhoumi, W.
    Elfatmi, R.
    Ladeb, S.
    Menif, S.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S144 - S144
  • [8] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) FOR PRIMARY PLASMA CELL LEUKEMIA (PPCL): A PROSPECTIVE STUDY OF IFM GROUP
    Charbonnier, A.
    Michalet, M.
    Xhaard, A.
    Karlin, L.
    Fermand, J. P.
    Wetter-Wald, M.
    Yacoub-Agha, I.
    Chantepie, S.
    Chevallier, P.
    Fuzibet, J. G.
    Ledoux, M. P.
    Maillard, N.
    Roussel, M.
    Belhadj, K.
    Brechignac, S.
    Benboubker, L.
    Royer, B.
    HAEMATOLOGICA, 2014, 99 : 165 - 165
  • [9] Rare minimal residual disease (MRD) and small amount of carrier lymphocytes in adult T cell leukemia/lymphoma (ATLL) patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
    Yamasaki, Reishi
    Miyazaki, Yasushi
    Ando, Koji
    Sawayama, Yasushi
    Inoue, Yoriko
    Matsuo, Emi
    Tsutsumi, Chizuko
    Taguchi, Jun
    Imaizumi, Yoshitaka
    Imanishi, Daisuke
    Honda, Miyuki
    Fujimoto, Takeshi
    Tsushima, Hideki
    Fukushima, Takuya
    Yoshida, Shinichiro
    Honda, Sumihisa
    Hata, Tomoko
    Moriuchi, Yukiyoshi
    Tsukasaki, Kunihiro
    Tomonaga, Masao
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 586 - 586
  • [10] Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for 67 Pediatric Patients with High Risk T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Liu, De-Yan
    Cao, Xing-Yu
    Zhang, Jian-Ping
    Xiong, Min
    Zhao, Yan-Li
    Zhou, Jia-Rui
    Lu, Yue
    Lu, Pei-Hua
    Lu, DaoPei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345